DISCOID LUPUS ERYTHEMATOSUS

Clinical trials for DISCOID LUPUS ERYTHEMATOSUS explained in plain language.

Never miss a new study

Get alerted when new DISCOID LUPUS ERYTHEMATOSUS trials appear

Sign up with your email to follow new studies for DISCOID LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental injection aims to tame stubborn lupus skin lesions

Disease control Terminated

This study tested whether a new injectable medication called daxdilimab could reduce skin disease activity in adults with moderate-to-severe discoid lupus, a condition causing scarring skin rashes. About 72 participants received either the drug or a placebo shot every four weeks …

Matched conditions: DISCOID LUPUS ERYTHEMATOSUS

Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 16, 2026 15:24 UTC

DISCOID LUPUS ERYTHEMATOSUS

Get alerted when new DISCOID LUPUS ERYTHEMATOSUS trials appear

Experimental injection aims to tame stubborn lupus skin lesions